Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Jan 19, 2005

30339_dirs_2005-01-19_cbaf390f-320d-4255-8beb-8d5db423ae7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-01-14

Reporting Person: ALTEMUS LINDA R (VP & Chief Compliance Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-01-14 Common stocks M 4000 $13.0157 Acquired 21900.9914 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-01-14 Stock Option (Right to Buy) $13.0157 M 4000 Disposed 2010-03-25 Common Stock (4000.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stocks 1370.8321 Indirect
Common stocks 2961.2245 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.